Nirsevimab: How One Injection Is Giving Infants a New Shield Against RSV
A long-acting antibody is changing how doctors protect babies from respiratory syncytial virus, offering the youngest patients direct protection during…
EXPLORE THE COLLECTION
Medicine
TIL Therapy: How a Patient’s Own Immune Cells Are Opening a New Front Against Solid Tumors
The first FDA-approved cellular therapy for a solid tumor turns immune cells taken from a patient’s melanoma into a one-time…
A Personalized Stem-Cell Transplant Helped a Woman With Type 1 Diabetes Make Her Own Insulin Again
A small but remarkable clinical advance shows how a patient’s own cells might one day be reprogrammed into insulin-producing tissue—while…
The First FDA-Cleared Alzheimer’s Blood Test Is Bringing Diagnosis Closer to Everyday Care
A blood test that detects Alzheimer’s-related proteins has received FDA clearance, offering doctors a simpler way to help identify the…
CAR-T Therapy Is Moving Beyond Cancer—and Toward a New Immune-System Reset
The cell therapy that transformed treatment for some blood cancers is now being tested in lupus, systemic sclerosis, and other…
Gene Therapy Is Giving Some Children Born Deaf a New Way to Hear
Early clinical studies are testing whether a repaired gene can restore the inner-ear machinery that some children never had. The…
Lenacapavir: How a Twice-Yearly Injection Could Change HIV Prevention
A new long-acting medicine is giving HIV prevention a different rhythm: instead of remembering a pill every day, eligible people…
The Malaria Vaccine Is Moving From Breakthrough to Childhood Protection
After decades of research, two WHO-recommended malaria vaccines are beginning to reach children in the places where the disease remains…
Casgevy: How CRISPR Gave Sickle Cell Medicine a New Future
The first FDA-approved CRISPR medicine is not a laboratory curiosity. It is a painstaking, personalized treatment designed to help people…